Palliative sedation in end of life care
Lozano, Joe Fritz; Carranza, Ronald; Galang, Jaworski (2023)
2023
All rights reserved. This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:amk-202405079818
https://urn.fi/URN:NBN:fi:amk-202405079818
Tiivistelmä
Adequate symptom relief ought to be the standard of care for terminally ill. In spite of excellent palliative care, some patients experienced intolerable, uncontrollable pain and suffering from refractory symptoms. Palliative sedation was considered an acceptable treatment at the end of life for refractory symptoms.
The purpose of this study was to described the used of palliative sedation in end-of-life care as well as the drugs used in palliative sedation. This study aimed to provide further information and gain more knowledge on the utilization of palliative sedation in end-of-life care that will guide nurses and other health care practitioners in their scope of practice.
The articles were synthesized from the credible databases CINAHL and PubMed. Total of 15 academic articles including five qualitative and ten quantitative studies were reviewed. The articles included were published between Jan 2013 – Sep 2023. This study utilized descriptive literature review as a researched method and the data were analyzed using inductive content analysis.
The result of the study showed that the main indication of palliative sedation was to treat refractory symptoms. The sedative drugs utilized in palliative sedation were benzodiazepines particularly midazolam and anti psychotic neuroleptic such as haloperidol. In addition, non sedative drugs were also used in palliative sedation such as opioids.
This study will introduce palliative sedation as treatment of refractory symptoms. It will increase the knowledge of nurses on refractory symptoms and further understand the drugs utilize in palliative sedation to treat patients with terminal illness. The approach to patient treatment is multidisciplinary, thus it is in the best interest to be equipped with the necessary scientific knowledge and skills to carry out their task.
The Turnitin program was utilized to checked the origin of this study, which produced a similarity percentage within acceptable limits.
The purpose of this study was to described the used of palliative sedation in end-of-life care as well as the drugs used in palliative sedation. This study aimed to provide further information and gain more knowledge on the utilization of palliative sedation in end-of-life care that will guide nurses and other health care practitioners in their scope of practice.
The articles were synthesized from the credible databases CINAHL and PubMed. Total of 15 academic articles including five qualitative and ten quantitative studies were reviewed. The articles included were published between Jan 2013 – Sep 2023. This study utilized descriptive literature review as a researched method and the data were analyzed using inductive content analysis.
The result of the study showed that the main indication of palliative sedation was to treat refractory symptoms. The sedative drugs utilized in palliative sedation were benzodiazepines particularly midazolam and anti psychotic neuroleptic such as haloperidol. In addition, non sedative drugs were also used in palliative sedation such as opioids.
This study will introduce palliative sedation as treatment of refractory symptoms. It will increase the knowledge of nurses on refractory symptoms and further understand the drugs utilize in palliative sedation to treat patients with terminal illness. The approach to patient treatment is multidisciplinary, thus it is in the best interest to be equipped with the necessary scientific knowledge and skills to carry out their task.
The Turnitin program was utilized to checked the origin of this study, which produced a similarity percentage within acceptable limits.